Bing

SEARCH HISTORY

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) opened at 125.08 on Tuesday. Vertex Pharmaceuticals Incorporated has a 52-week low of $63.68 and a 52-week high of $137.50. The stock has a 50-day moving average of $126. and a 200-day moving …
Ticker Report · 5/26/2015
Impax Laboratories (IPXL): IPXL stock is down 2.0% today. Novartis Ag (NVS): NVS stock is down 2.0% today. Vertex Pharmaceuticals Inc (VRTX): VRTX stock is down 2.0% today. For more information on the best stocks to buy right now, check out the …
Investor Place · 5/26/2015
The headlines after this month's FDA advisory committee meeting reviewing Vertex Pharmaceuticals' (NASDAQ: VRTX) cystic fibrosis drug Orkambi ... the two drugs would be detrimental to the Vertex's stock price.
Investopedia · 5/28/2015
More from Bing News
One of the S&P 500’s big winners for Wednesday May 27 was Vertex Pharmaceuticals Incorporated ($VRTX) as the company’s stock climbed 4.22% to $127.80 on volume of 1.38 million shares. The stock opened at $123.23 and saw an intraday low of …
Equities · 5/27/2015
Vertex Pharmaceuticals (NASDAQ:VRTX), a company whose shares are moving quickly ... based on a current level of $125.97 and analysts' average consensus price target of $136.60. The stock should discover initial support at its 50-day moving average ...
Financial News Network Online · ByPeter Chu · 5/27/2015
BioMarin (BMRN), Vertex (VRTX), and Alnylam (ALNY) are turning in some of the biotech sector's best performances. Semiconductor, pharmaceutical, and computer hardware stocks are also seeing significant strength …
Realtime Business News · 5/27/2015
Community Health Systems (CYH)- The company’s stocks retreated 1.6 pct. Hms Holdings Corp (HMSY)- The company’s shares dropped 1.4 pct. Vertex Pharmaceuticals Inc (VRTX)- The company’s shares …
Fx Pips · 5/22/2015
The next best performing sector is the Healthcare sector, up 0.9%. Among large Healthcare stocks, Universal Health Services, Inc. (NYSE: UHS) and Vertex Pharmaceuticals, Inc. (NASD: VRTX) are the most notable …
Forbes · 5/27/2015
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was criticized on Wednesday by proxy advisory ... The total pay amounts to $45.8 million, inclusive of stock options based on current market value. “The total …
bidnessetc.com · 5/27/2015
NEW YORK (TheStreet) -- Vertex Pharmaceuticals (VRTX - Get Report) shares are up 2.11% to $126.70 in trading on Wednesday after the biopharmaceutical company announced that a Food and Drug Administration advisory panel backed its cystic …
The Street · 5/13/2015
Related Searches